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Abstract 
Background: With the publication of two randomized controlled trials (RCTs) in 
2002, therapeutic hypothermia (TH) was re-introduced in postresuscitation care of 
comatose out-of-hospital cardiac arrest (OHCA) patients. Many issues, however, were 
unresolved, including implementation protocol, cooling technique, clinical 
management, implications of TH treatment on prognostic accuracy and therapeutic 
benefit in subgroups of OHCA excluded from the initial RCTs. Objectives: We 
wanted to study the implementation of therapeutic hypothermia into daily practice, 
provide information on clinical management, including differences in cooling 
techniques and test application in elderly OHCA patients excluded in earlier trials. 
Subjects: We evaluated the clinical management of adult comatose OHCA patients 
who were treated in our ICU (paper I and IV). In paper II we surveyed our intensive 
care nursing staff with regard to key nursing aspects of different cooling methods and 
devices. In paper III, ICU consultants were assessed on their prognostic approach in 
OHCA patients treated with TH. Methods: In paper I we retrospectively compared 
OHCA patients treated with TH with a historic control group of OHCA patients 
fulfilling the TH inclusion criteria. We collected Utstein template data, as well as data 
on ICU-and hospital length of stay (LOS), incidence of adverse events, and outcome 
at hospital discharge and after one year. In paper II an anonymous survey was 
conducted with our intensive care nursing (ICN) staff, assessing ease of application, 
hygiene, work load, noise level and visual patient monitoring of four different cooling 
methods. In paper III we used a semi-structured telephone interview to conduct a 
nation-wide survey of the prognostication approach of comatose OHCA patients 
involving timing, methods, involved specialties and rating of prognostic methods. In 
paper IV we retrospectively studied outcome variables in all adult OHCA patients 
treated with TH in our ICU over a six-year period, who fulfilled the Hypothermia 
After Cardiac Arrest study (HACA) criteria with exception of the upper age limit. 
Results: With our simple cooling protocol we achieved 100% implementation and 
successful attainment of target temperature (TT) in 89% of patients (paper I). 
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However, it took median 7, 5 hours (1-10 h) to reach TT, which was maintained for 
median 10 hours (6-19h). Demographics, Utstein template data, ICU and hospital 
LOS did not differ significantly between the two groups. Insulin resistance and 
hypokalemia were significantly more frequent in the TH group, whereas seizures were 
observed more frequent in the normothermia group. The TH group showed 
significantly higher rates of survival to hospital discharge (59% vs. 32%, p = 0, 05). 
In paper IV we found that although older age influenced outcome, over half of OHCA 
patients older than 75 years showed favorable outcome at hospital discharge. The four 
cooling methods used in our department differed significantly regarding key nursing 
aspects (paper II). Our simple cooling method scored high regarding ease of 
application and noise level, but low in work load and hygiene. The CoolGard and 
ArticSun systems scored highest in work load and hygiene. Only 53% of ICNs were 
satisfied with their initial training and merely 10% felt adequately prepared at the time 
when TH was introduced. In paper III we found that even after introduction of TH, 
prognostication after OHCA was performed within 48 hours in the majority of 
patients. More than one specialty was involved, using mainly clinical neurological 
examination (100%), prehospital data (76%), cerebral computer tomography (CCT) 
(58%) and electroencephalography (EEG) (52%) findings. Somatosensory evoked 
potentials (SSEP) (8%), biochemical markers (8%) and magnetic resonance imaging 
(MRI) (8%) only played a minor role. Only one ICU used a standardized protocol. 
Conclusions: Our simple external cooling protocol could be rapidly implemented, 
was safe, cheap and feasible, but not optimal with regard to accurate temperature 
management (paper I). Key nursing elements differed significantly among available 
cooling methods (paper II). Even though age influences outcome, more than half of 
our OHCA population older than 75 years showed good outcome. The limitation of 
patient eligibility for TH treatment should not be based on age alone (paper IV). 
Despite frequent use of TH, prognostication after OHCA was executed early, mainly 
based on clinical examination, prehospital data, CCT and EEG results. SSEP seems to 
be underused and underrated, whereas the clinical accuracy of CCT, prehospital data 
and EEG seems to be overrated (paper III).
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1. Introduction 
 
1.1  Sudden cardiac arrest 
For the greater part of human history, mankind believed that death is irreversible. 
Even though anatomical and pathophysiological essentials of cardiac arrest were 
known for centuries, it took until the 1960s before cardiopulmonary resuscitation  
(CPR) with artificial ventilation, mechanical chest compressions and defibrillation 
became a clinically practicable concept.1 
Sudden cardiac arrest implies a death from natural causes, characterised by three 
elements: natural process, rapid progress and unanticipated occurrence ensuing less 
than one hour from the onset of symptoms.2 The International Liaison Committee on 
Resuscitation (ILCOR) defines cardiac arrest as the „cessation of cardiac mechanical 
activity, as confirmed by the absence of signs of circulation”.3  
Circa 275.000 Europeans experience sudden cardiac arrest treated by the emergency 
medical services (EMS) per year.4 With the cessation of circulation, starts a process, 
which, if no intervention is performed, ultimately leads to death. Usually, there are 
two recognised systems of “biological death”: a) irreversible cardiac arrest and b) 
brain death.5  Thus, within the time frame between cardiac arrest and the development 
of irreversible neurological injury, resuscitative efforts have to be commenced if 
meaningful survival is pursued.  
In cases of sudden cardiac arrest, the patient has usually functional vital organs 
systems and most commonly unrecognized ischemic heart disease.6,7 Other causes of 
sudden cardiac arrest include arrhythmic heart disease, cardiomyopathy, inflammatory 
myocardial disease, valvular disease, pulmonary diseases, pulmonary embolism, 
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cerebral nervous system disease, vascular catastrophies, drugs, toxins, trauma, non-
traumatic bleeding and drowning.8,9 
1.1.1 Types of cardiac arrest 
Several types of cardiac arrest can be differentiated: adult vs. paediatric, presumed 
cardiac origin vs. non-cardiac origin, in-hospital (IHCA) vs. out-of-hospital (OHCA). 
The various types of cardiac arrest differ significantly in incidence, aetiology, 
prognosis and causes of mortality. 
Paediatric cardiopulmonary resuscitation differs from adult CPR, as children present 
different anatomy, physiology and pathogenesis of cardiac arrest. Most paediatric 
cardiac arrests are secondary to hypoxia or circulatory failure; nevertheless 7-10% are 
precipitated by ventricular fibrillation or tachycardia.10 Recent data suggests a 10% 
chance of survival to discharge in patients over 1 year and OHCA.11 The majority of 
adult patients experiencing cardiac arrest suffer from cardiac disease, mainly 
unrecognised ischemic heart disease.7 Non-cardiac arrest aetiology is reported in 
25%-34% and it includes trauma, non-traumatic bleeding, intoxication, drowning, 
obstructive pulmonary disease and pulmonary embolism.8,9,12 The survival rate of 
non-cardiac arrest is substantially lower than survival after cardiac arrest of cardiac 
origin. 8 Cardiac arrests are usually classified as in-hospital (IHCA) or out-of-hospital 
(OHCA) according the location of the cardiac arrest. In-hospital and out-of-hospital 
cardiac arrest differ significantly in incidence, aetiology, prognosis and causes of 
mortality.13  
In addition, the first recorded electrocardiographic (ECG)-rhythm is often used to 
categorize cardiac arrest. There are four main rhythms associated with circulatory 
arrest: ventricular fibrillation (VF), non-perfusing ventricular tachycardia (VT), 
pulseless electrical activity (PEA) and asystole. The first two are usually grouped 
together as “shockable rhythm”.14 VF is described as uncoordinated  heart action with 
a high metabolic demand and lack of effectual contractions.15 Pulseless electric 
activity (PEA) is characterised by absent central or peripheral pulses and an 
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electrocardiographic rhythm other than VF/VT. Asystole is defined by the absence of 
pulses and electrocardiographic activity.  The different cardiac rhythms are strong 
indicators of survival and outcome. Patients found in VF or non-perfusing VT have a 
significantly better chance of good outcome than patients in asystole or PEA.16 
The incidence of VF/VT as the initial recorded ECG- rhythm is approximately 40 %. 
12,16,17 The probability of the initial rhythm being VF/VT changes with the time period 
between onset of cardiac arrest and initial ECG, since VF fades in amplitude and 
regresses into asystole or PEA.18 The overall incidence of sudden cardiac arrest and 
particularly the occurence of VF/VT have decreased over the past decades.17,19  
This thesis has exclusively studied OHCA of presumed cardiac cause in adults. 
1.1.2 Epidemiology of cardiac arrest 
The estimated overall incidence of out-of-hospital cardiac arrest (OHCA) lies 
between 40 and 130 per 100.000 inhabitants per year  and increases with age from 0,9 
person-years for the population aged between 18-50 to 8,5 person-years for subjects 
aged over 80 years.20 The incidence of EMS-treated cardiac arrests in Europe and 
North America is about 55/100.000 person/years for all rhythm cardiac arrest and 
15/100.000 for VF cardiac arrest.4,21 
When cardiopulmonary resuscitation is attempted, a return of spontaneous circulation 
(ROSC) may be achieved in 17-49% of the victims.22 Unfortunately, ROSC is merely 
the first step in survival after out-of-hospital cardiac arrest. Almost 80% of patients, 
who initially survive, remain in a coma for varying lengths of time and are admitted to 
an intensive care unit (ICU).23 Data on OHCA patients admitted to the hospital 
suggest a wide regional and institutional disparity in in-hospital mortality ranging 
from 41-90%.24 The majority of all deaths after OHCA are due to neurological injury 
and myocardial dysfunction.25,26 Even though critical care is progressing 
continuously, overall survival from OHCA has been stable for the last three 
decades.27 
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1.1.3 History and physiology of cardiopulmonary resuscitation  
Throughout most of the recorded history of mankind, cardiac arrest was usually a fatal 
event and the natural ending of life. It was not until the end of the 18th century before 
resuscitation was deemed possible. However, it took more than 200 years before 
skills, knowledge and technology for cardiopulmonary resuscitation became a clinical 
reality in the 1960s.1  Studies on artificial ventilation were already performed by 
Vesalius in the 16th century, but it was the work of Elam, Safar, and Gordon and the 
demonstration of the superiority of mouth-to-mouth ventilation over the traditionally 
used manual method in 1958 that convinced the medical community.28 In 1960, 
Kouwenhoven and colleagues published their work on closed chest cardiac massage 
as a new treatment for cardiac arrest. 29 Artificial respiration and chest compression 
were then combined to create cardiopulmonary resuscitation (CPR) and in 1966 the 
Cardiopulmonary Resuscitation Committee on CPR reported its recommendations.1 
Electrical defibrillation was first successfully applied internally in 1947 and externally 
in 1956.30,31 With the development of portable DC-defibrillators by Lown and 
colleagues, prehospital CPR was possible. 32 By the late 1960s, CRP, defibrillation 
and evolving emergency medicine services systems were all in place. Dispatcher-
assisted CPR to direct bystanders was introduced in the late 1980s.33 The International 
Liaison Committee on Resuscitation (ILCOR) was established in 1992 and provides 
evidence-based guidelines for basic (BLS) and advanced life support (ACLS)34. BLS 
involves chest compressions and artificial ventilation, ACLS, in addition, drug 
administration, defibrillation and airway management.35  
Pathophysiology 
Following cardiac arrest some blood flow continues for several minutes until the 
pressure gradient between aorta and right heart equilibrates. The decrease in arterial 
pressure and the increase in right atrial pressure lead to right ventricular dilatation and 
distortion of the interventricular septum. Chest compressions result in an antegrade 
flow in the aorta and the pulmonary artery during the compression phase and in a 
retrograde flow during the decompression phase.  Coronary flow is reverse compared 
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to the flow pattern of the major blood vessels during compression and decompression. 
36 Cardiac output during optimal CPR is between 25-50% of pre-arrest values. 37 CPR 
decompresses the right ventricle, fills the left heart and coronary arteries and mitigates 
end-organ ischemic injury by providing crucial organ perfusion.38,39 Weisfeldt and 
Becker´s “three phase time sensitive model” of cardiac arrest focuses on optimizing 
treatment for cardiac arrest according to specific phases:  The electrical phase where 
the heart corresponds to defibrillation, followed by the circulatory phase where chest 
compressions are required prior to defibrillation and the metabolic phase where 
therapies address the ischemia and reperfusion injury. 40  
The risk of poor outcome is increased by expanding time intervals between distress 
call and arrival of the ambulance, collapse and commencement of CPR, absence of 
bystander CPR as well as every minute that defibrillation is deferred. 41-43  The chain 
of survival for a patient in cardiac arrest contains therefore early recognition and call 
for help, early CPR, early defibrillation and good post resuscitation care. 14 
 
 
Figure 1.            Chain of survival 
Copyright European Resuscitation Council. www.erc.edu 
Historically, most focus and resources were directed to the first three links of the 
chain of survival.  The importance of good and early post resuscitation care has lately 
been recognized and several studies have associated variations in OHCA outcome to 
differences in post resuscitation treatment.44-46 The 2010 resuscitation guidelines 
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acknowledge the major potential influence of post resuscitation care on lowering in-
hospital mortality caused by post cardiac arrest syndrome.14,47 
1.1.4 Pathophysiology of cardiac arrest and post-cardiac arrest 
syndrome 
As blood flow ceases, cell injury is commenced by whole-body ischemia and then 
augmented by return of circulation, also named reperfusion. 48 The ischemic injury 
starts relatively slowly, then gathers momentum and finally plateaus. 49 Many of the 
damaging mechanisms after ischemia and reperfusion are executed over an interval of 
hours to several days and cellular models suggest that up to 70% of cell deaths can be 
attributed to reperfusion injury rather than ischemia alone. 40,50,51  
The mechanisms of global ischemia and reperfusion are diverse, complex and not 
fully understood, involving abrupt cellular energy exhaustion with adenosine-
triphosphate (ATP) breakdown, change to anaerobic metabolism, intra-and 
extracellular acidosis, intracellular calcium overload, mitochondrial dysfunction, 
activation of intracellular enzymes, glutamate release, neuroexcitatory cascades, 
increased free radical production, apoptosis and inflammatory response. 52  
The distinct pathophysiological changes after cardiac arrest - termed            
“postresuscitation disease” by Negovsky in the late 1980`s – are characterized by four 
mechanisms: (1) perfusion failure, (2) reoxygenation injury, (3) extracerebral causes, 
like post anoxic viscera and blood stasis.53,54 Post-cardiac arrest inflammation 
increases secondary neuronal damage via activation of blood coagulation and platelets 
as well as excessive liberation of pro-inflammatory mediators, expression of 
endothelial adhesion molecules, accumulation of inflammatory cells in the injured 
brain tissue and increased nitric oxide production.52 The immuno-inflammatory 
profile of post-cardiac arrest patients resembles that of patients in sepsis.55 
The clinical entity of pathophysiological changes has been termed post cardiac arrest 
syndrome and is causative to 87% of all in-hospital deaths after OHCA.26 The 
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International Liaison Committee on Resuscitation (ILCOR) defines the four key 
elements of post-cardiac arrest syndrome as: (1) post-cardiac arrest brain injury, (2) 
post-cardiac arrest myocardial dysfunction, (3) systemic ischemia/reperfusion 
response, and (4) persistent precipitating pathology.24  
Clinical symptoms of post-cardiac arrest brain injury comprise coma, seizures, 
myoclonus and varying degrees of neurophysiological impairment, varying from 
slight memory dysfunction to brain death.24 Almost 80% of patients who initially 
survive an OHCA remain comatose and are admitted to an ICU, where approximately 
17%-68% of patients after OHCA and 23% of IHCA will succumb to post-cardiac 
arrest brain injury. 23,25,26 Good cerebral outcome occurs in only 11-48% of patients 
discharged from the hospital. 54 
Two categories of neuronal cell death are recognised in ischemia: neuronal necrosis 
ensues hypoxia during the cardiac arrest, whereas apoptosis and multifocal micro 
infarcts characterise reperfusion injury.56 Protracted neuronal necrosis and apoptosis – 
triggered by various pathways - is enhanced in selectively vulnerable neuron 
populations, like the hippocampus, cortex, cerebellum, corpus striatum, basal ganglia, 
thalamus and spinal cord. 57  
Dysregulation of cerebral blood flow (CBF) after ROSC is characterized by early 
hyperemia followed by a phase of delayed reduction in CBF as well as 
microcirculatory reperfusion failure.58,59 The length of the hyperemic phase as well as 
the extent of the areas with no or reduced reflow is proportional to the duration of 
ischemia.60,61 Microcirculatory reperfusion failure- also termed no-reflow- in spite of 
adequate cerebral perfusion pressure has been ascribed to intravascular thrombosis.62  
Additionally, there is evidence of impaired cerebral autoregulation and disruption of 
the blood-brain-barrier (BBB) with edema formation.59,63 During the subacute phase 
after resuscitation, cerebral vascular resistance is increased while CBF, cerebral 
metabolic rate of oxygen (CMRO2) and glucose consumption are decreased.64,65  
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Hypotension, hypoxia, hyperoxia, seizures, hyper-and hypoglycemia as well as 
hyperthermia all aggravate secondary brain damage after cardiac arrest.24 Hyperoxic 
reperfusion after ROSC seems to increase oxidative stress, promote inflammation and 
is associated with worse neurologic outcome and increased mortality.66-68 
Hyperthermia in particular has been shown to impact outcome after cardiac arrest. For 
every degree of a peak temperature greater than 37°C, the risk of unfavorable 
outcome increases significantly.46,69 
 Post-cardiac arrest myocardial dysfunction (PCAMD) is a critical factor impacting 
both mortality after OHCA and neurological outcome. 26 Approximately 50% of all 
OHCA survivors experience PCAMD, involving systolic and diastolic dysfunction of 
both the right and left ventricle.70-72 The incidence of PCAMD is related to the 
duration of CPR, amount of administered adrenaline, number of shocks applied, age, 
arrest-to-defibrillation interval, arrest-to-PCI interval and prearrest myocardial 
function.26,72 Myocardial dysfunction is the primary cause of death within the 24 
hours after ROSC.26  
After re-establishment of coronary blood flow to the ischemic myocardium, 
reperfusion injury can occur,  promoting further myocardial damage and decreasing 
the benefit of coronary reperfusion therapy.26 PCAMD is caused by reversible 
myocardial stunning, no-reflow phenomenon, microvascular dysfunction, reperfusion 
arrhythmia and a profound systemic inflammatory response syndrome, usually 
resolving within 72 hours in OHCA survivors.26,40,55,70 Attainment of core body 
temperature below 35°C before percutaneous coronary intervention (PCI) and 
reperfusion in cardiac arrest patients with acute coronary syndrome (ACS) was 
associated with a substantial reduction in infarct seize.73  
Both early arterial hypotension, defined by a systolic blood pressure below 90 mm 
Hg, and absence of early goal-directed hemodynamic optimization were associated 
with worse outcome.74,75  
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The severe shock and global ischemia of cardiac arrest prompts activation of 
coagulation, platelets and endothelium as well as a systemic inflammatory response. 
This leads to microcirculatory dysfunction, reperfusion disorders, impaired vasotonus, 
adrenal dysfunction, reduced oxygen delivery, increased gut mucosal translocation, 
immunosuppression and ultimately multiple organ failure and death. 24,54,55 Adrie and 
colleagues examined the immunological status of OHCA patients and found a 
resemblance to patients in sepsis with high concentrations of cytokines, detection of 
plasma endotoxin and cytokine dysregulation.55 Post-ischemic cerebral inflammatory 
response involves microglia activation, endothelial adhesion molecules production 
and leukocyte migration and activation.76  
An additional factor contributing to in-hospital mortality of OHCA survivors is the 
persisting precipitating pathology that caused the cardiac arrest. Numerous etiologies 
are associated with cardiac arrest and their causal treatment is essential for the 
patients‘survival. Cardiac causes of arrest are presumed in approximately 80% of all 
OHCA, the majority suffering from unrecognised ischemic heart disease and acute 
coronary syndrome.6,7 Autopsy findings suggest an acute coronary event in 57%-73% 
of sudden OHCA patients without chronic heart failure and in 33% of OHCA patients 
with chronic heart failure.7,77,78 In contrast, merely 11% of adult in-hospital cardiac 
arrests were ascribed to acute coronary syndromes.79  Non-cardiac arrest aetiology is 
reported in 25-34 %.8,12 Given the high occurrence of ACS in OHCA patients, the 
International Liaison Committee on Resuscitation (ILCOR) recommends immediate 
coronary angiography (CAG) and percutaneous coronary intervention (PCI) in OHCA 
patients with ST-elevations myocardial infarction (STEMI) and the consideration of 
CAG and PCI in all OHCA patients.24  
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1.1.5 Documentation of cardiac arrest 
The 1991 Utstein-style template and its 2004 update by ILCOR have been the 
standard for uniform reporting of OHCA for the past two decades.3,80 Outcome data 
points are the percentage of patients discharged alive from hospital and the 
neurological status defined by the Glasgow-Pittsburgh Cerebral Performance 
Category (CPC).80  
1.2 Post-cardiac arrest intensive care 
Whereas the importance of the electrical and circulatory phases of Weisfeldt`s  
cardiac arrest model was early recognized, has the metabolic phase long been 
confined to establishing extracranial homeostasis by providing general supportive 
ICU care. 40 The 2000 ERC post resuscitation care guidelines targeted the transport of 
the patient to an ICU, the optimization of tissue oxygenation with cardiorespiratory 
support, anti-arrhythmic therapy, the identification of the cause of the arrest and the 
consideration of fibrinolysis or PCI in STEMI. Hypocapnia and even mild 
hypotension should be avoided. Electrolyte abnormalities and fever should be treated, 
seizures controlled. Patients who were hemodynamically stable and mildly 
hypothermic (> 33°Celcius) should not be actively warmed but hypothermia should 
not be induced after cardiac arrest.81 The importance of good and early post 
resuscitation care has lately been recognized and several studies have associated 
variations in OHCA outcome to differences in post resuscitation treatment.44-46 
In the attempt to mitigate the reperfusion injury, a wide array of neuroprotective 
medications has been studied without leading to evidence that they improve outcome 
after OHCA.24 
The simultaneous publication of two landmark studies in 2002 showed that reduction 
of core temperature to 32°C-34°C for 12-24 hours, obtained within hours after return 
of spontaneous circulation (ROSC) in VF-OHCA, improved survival and neurological 
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outcome.82,83 The International Liaison Committee on Resuscitation (ILCOR) 
acknowledged the published evidence by making an advisory statement in 2003 
recommending cooling adult unconscious VF-OHCA survivors to 32°C-34°C for 12-
24 hours. Additionally, it was stated that hypothermia could be beneficial in cardiac 
arrests presenting with other rhythms than VF and in in-hospital cardiac arrest.84 The 
re-discovery of hypothermia treatment in post resuscitation care sparked a paradigm 
shift from cardiopulmonary resuscitation (CPR) to cardiopulmonary-cerebral 
resuscitation (CPCR) and a new interest for neuroprotective measures in intensive 
care medicine. 85  
1.3 Therapeutic Hypothermia  
Therapeutic hypothermia (TH) is defined as “the controlled lowering of core 
temperature for therapeutic reasons”.86 Temperature ranges for hypothermia are 
categorized as: mild (34°C-35,9°C), moderate (32°C -33,9°C), moderate-deep (30°C-
31,9°C) and deep (< 30°C).87  
Several others synonyms for therapeutic hypothermia used in the literature are 
controlled hypothermia 88, induced hypothermia 86, mild hypothermia 89, and targeted 
temperature management. 90  
TH was introduced in the operating room in the 1950s as a neuroprotective measure 
for intracerebral aneurysm procedures and for cardiac surgery involving complete 
cardiac arrest.91-94 Studies on the use of resuscitative hypothermia after cardiac arrest 
outside the operating room in a small number of patients were conducted in the late 
1950s. In 1964, Peter Safar recommended to start TH within 30 minutes in comatose 
cardiac arrest survivors in his “first ABCs of resuscitation” (fig.2).95-97 In their review 
on the treatment of the comatose patient, Rosomoff and Safar provide early guidelines 
for neurointensive care stating that fever is harmful, temperature rises above 38°C 
should be avoided by external cooling and “hypothermia seems indicated in any 
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patient who has brain damage severe enough to produce unconsciousness- usually the 
temperature is kept at 32°C”.96 
 
Figure 2.        Peter Safar´s “first ABCs of resuscitation  
Reprinted with permission, from Journal of the Iowa Medical Society 97 
However, the technique did not gain popularity since the application of moderate to 
deep rather than mild hypothermia for prolonged periods as well as practical 
management problems exhibited an increased rate of side effects in combination with 
indeterminate clinical outcome improvement. 98-100   
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 Even though interest in the technique was renewed in the 1980s by positive animal 
studies, no randomised controlled trials for the use of TH in cardiac arrest patients 
were published until 2001.86,101 However, as early as 1993, Bernard and colleagues 
had started a prospective clinical trial to evaluate the effect of moderate hypothermia 
(33°C for 12 h) in comatose survivors of OHCA who compared to a retrospectively 
studied normothermic control group. They found a significant increase in survival 
with no increase in adverse events.102 
1.3.1 Protective mechanisms of TH 
The pathophysiology of hypoxic-ischemic and reperfusion injury in cardiac arrest is 
very complex and not fully understood.24 However, a common denominator of the 
destructive cellular events is their temperature dependence.87 The mechanisms by 
which therapeutic hypothermia exerts its protective effects on the different 
pathophysiological cascades, triggered by the circulatory arrest phase and the 
following reperfusion, are still subject to investigation. Figure 3 shows a schematic 
overview of TH-associated protective effects.52,54,86,87 
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Figure 3.  Protective mechanisms of hypothermia  
1.3.2 Therapeutic hypothermia after cardiac arrest 
In 2001, the first randomised trial was published by Hachimi-Idrissi and colleagues. It 
enrolled 30 unconscious non-VF-OHCA survivors in a cooling-helmet- feasibility 
study. The patients were cooled for 4 hours to 34°C and then passively rewarmed. 
Although the trial was underpowered to reach statistical significance with regard to 
outcome, it showed a favourable outcome in 13% of the hypothermia treated patients 
versus 0% in the normothermic group with no rise in complications. 103 
Then, in 2002, the New England Journal of Medicine published two RCTs on mild 
therapeutic hypothermia in comatose OHCA patients, one from Melbourne, Australia 
and one multicentre study from Europe.82,83 The Australian trial included 77 comatose 
OHCA survivors. All cardiac arrests were of presumed cardiac origin with VF or non-
Therapeutic 
hypothermia 
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perfusing VT as first initial ECG-rhythm. The group treated with hypothermia was 
cooled to 34°C within 2 hours of ROSC and maintained at that temperature for 12 
hours. Favourable neurological outcome was significantly more frequent in the 
hypothermia group (49%) than in the normothermic group (26%) at hospital 
discharge. Moreover, this trial also did not report significant side effects of the 
hypothermia treatment.82 
The Hypothermia After Cardiac Arrest study (HACA) conducted in Europe enrolled 
275 comatose OHCA survivors with cardiac-caused arrest and VF or non-perfusing 
VT as first initial ECG-rhythm. The hypothermia treated group was cooled to 32°C-
34°C for 24 hours. Favourable neurological outcome was recorded in 55% in the TH 
group versus 39% in the normothermia group at six months after the cardiac arrest. 
The rate of complications for both groups did not differ significantly.83 
The European and the Australian study involved a highly selected cluster of OHCA 
patients, including less than 10% of all assessed OHCA.83 Exclusion criteria are 
depicted in table 1.  Favourable neurological outcome of the initial randomized 
studies is depicted in figure 4. 
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HACA 83 BERNARD ET AL. 82 
NON-VF/non-perfusing VT NON-VF/non-perfusing VT 
< 18 years, > 75 years < 18 years, women < 50 years 
> 60 min. to ROSC No ROSC 
Non-cardiac origin of arrest Non-cardiac origin of arrest 
Evidence of hypotension (MAP < 
60mmHg > 30 min. after ROSC) 
Cardiogenic shock (systolic BP < 90 
mmHg despite epinephrine infusion) 
Pregnancy Women < 50 years 
Response to verbal commands after 
ROSC 
Not comatose after ROSC 
Comatose state due to CNS depressive 
drugs prior due cardiac arrest 
No ICU bed available 
< 30°C at hospital admission  
Evidence of hypoxemia ( arterial oxygen 
saturation < 85% > 15 min. after ROSC) 
 
Known coagulopathy  
Terminal illness  
Occurrence of cardiac arrest after arrival 
of emergency medical personnel  
 
ROSC- return of spontaneous circulation, ICU-intensive care unit 
Table 1.  Landmark studies exclusion criteria 
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Figure 4.  Randomized studies for TH after cardiac arrest. Favourable neurological 
outcome given as percentage at hospital discharge ( Hachimi-Idrissi 2001 and Bernard 
2002)  and at six month (HACA 2002) 
Following the publication of the Australian and European trials, ILCOR 
recommended the use of TH in comatose survivors after OHCA and that patients 
should be cooled to 32°C-34°C for 12-24 hours. Two randomized clinical trials 
supported the use in VF as initial ECG rhythm and one non-randomized, historical 
case-control study supported its use in other rhythm than VF/non-perfusing VT or in-
hospital cardiac arrest.84 For the patients treated with TH in the Australian study, 
cooling was initiated prehospitally by applying cold packs and continued after 
admission to the hospital with ice-packs over the head, neck, torso, and limbs. Target 
temperature was reached within 2 hours after ROSC.82  The European study used an 
external cooling device that delivered cool air over the body and supplemented the 
hypothermia treatment with ice packs if necessary. Target temperature was reached 
after median 8 hours (interquartile range 4-16 hours).83 
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1.3.3  Application of TH 
The increase of heat loss or the decrease of heat production achieves hypothermia. 
Mechanisms of heat loss include radiation, conduction, convection and evaporation 
and different cooling methods in post resuscitation care have been described (Table 
2).104 The age-dependent physiological response to a drop in core temperature is an 
increase in heat production by shivering which leads to an undesirable increase in 
metabolic rate and oxygen-consumption. Sedation and analgesia reduce the shivering 
threshold as well as shivering itself and seem to be crucial for TH-associated 
neuroprotection.87  
          Non-invasive                                                                   Invasive 
Ice packs                                                                Intravenous ice-cold saline 
Forced cold air (fans, blankets)                              Intravascular catheters 
Cooling pads                                                   Peritoneal, bladder, nasogastric cooling 
Water-circulating blankets                                       Intra-aortic flush cooling 
Cooling helmets                                                       Extracorporeal circulation 
Cold water immersion    
Transnasal evaporative cooling   
Antipyretic medication 
Table 2.  Cooling techniques87,105,106 
Phases of TH 
  The application of therapeutic hypothermia is usually divided into three segments: 
induction, maintenance and rewarming. The two landmark studies achieved target 
temperature within 2-8 hours in the majority of patients by external cooling.82,83 
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Whether early achievement of TH target temperature is beneficial for neurological 
outcome maintains a subject for debate. Animal data suggests that time to target 
temperature (TTT) is a predictor of good neurologic outcome and that intra-arrest 
cooling may even facilitate ROSC.107-109  
Most guidelines advocate inducing TH as soon as possible and maintaining a 
temperature of 32°C-34°C for 12 -24 hours without major temperature fluctuations. 
The rate of rewarming should be 0, 25°C-0, 5°C/hour. 14  
Adverse effects 
Hypothermia induces a wide array of physiological and pathophysiological changes. 
To what extent organ functions are altered depends upon the degree of hypothermia. 
Arrhythmia, shivering, haemodynamic instability, hypovolemia, ECG changes, 
coagulopathy, insulin resistance, pneumonia, electrolyte disorders, leukopenia, sepsis, 
renal failure, impaired bowel function, altered drug clearance, intracerebral bleeding, 
pancreatitis and pulmonary oedema are among potential complications associated 
with hypothermia.52,86 TH mitigates cerebral damage after cardiac arrest.86 The 
protective mechanisms not only amend the development of neurological injury, but 
also change the natural course of recovery of these patients. Moreover, TH in post 
resuscitation care necessitates active treatment with sedation, mechanical ventilation 
and sometimes muscle relaxation. Declines in drug clearance caused by hypothermia 
have been demonstrated for several commonly used ICU-drugs, e.g.: noradrenaline, 
adrenaline, opiates, midazolam, propofol, barbiturates, and muscle relaxants.87 
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1.4 Prognostication after cardiac arrest 
Approximately 80% of OHCA survivors remain in a coma for variable spans of time 
and about two-thirds of patients will later die during their hospital stay, the majority 
due to neurological injury.23,25 Persisting coma due to ischemic-anoxic 
encephalopathy is a severe condition and comas continuing for more than 3 days carry 
a risk of poor outcome of greater than 90 %. 110 After 1974, both traumatic and non-
traumatic coma has usually been classified using the Glasgow-Coma-Score (GCS, 
Box 1.). 111 
 
Box 1.  Glasgow-Coma-Score (GCS), score is calculated by summoning all modules, 
range: minimum 3- maximum 15, lower score equals more significant neurologic 
dysfunction 
For coma outcome, however, patients are commonly categorized in Glasgow-
Pittsburgh Cerebral Performance Categories (CPC, Box 2.).80  
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  Glasgow-Pittsburgh Cerebral Performance Categories 
1. Good cerebral performance: conscious, alert, able to work, possibly mild 
neurological or psychological deficit. 
2. Moderate cerebral disability: conscious, satisfactory cerebral function for 
independent activities of daily life or work in a sheltered milieu. 
3. Severe cerebral disability: conscious, reliant on others for daily support, 
institutionalized or at home with extraordinary family effort, limited cognition. 
Varying from ambulatory condition to severe dementia and locked-in-
syndrome. 
4. Coma, vegetative state: Not conscious, no cognition, no interactions with 
environment. 
5. Death: death by traditional criteria or brain death. 
Box 2. Glasgow-Pittsburgh Cerebral Performance Categories modified after.23 
Poor outcome after out-of-hospital cardiac arrest is usually defined as CPC > 2, 
describing states with total patient dependency. Since most patients would decide 
against a life with severe neurological disability and as health care for neurologically 
devastated individuals represents an enormous emotional, as well as socio-economic 
burden, the prospect of poor neurological outcome commonly initiates an assessment 
of adequacy to withdraw life support. 112,113  
In order to avoid “self-fulfilling prophecies” by early withdrawal on the one hand, and 
futile treatment on the other, reliable tests for cerebral prognostication with a false 
positive rate (FPR) of zero with narrow confidence intervals are warranted.   
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2. Objectives 
2.1 Main goals 
The overall objective of this thesis was to study the implementation of TH into daily 
practice, provide information on clinical management and outcome, and evaluate the 
application of TH in an age subgroup of OHCA patients not enrolled in earlier trials. 
2.2 Secondary objectives 
Paper I.        
We implemented a simple cooling protocol in our ICU and applied simplified 
inclusion criteria to OHCA patients. The aim was to evaluate feasibility, effectiveness 
and safety of a simple cooling protocol based on the two landmark studies as well as    
to support implementation of therapeutic hypothermia. 
Paper II. 
With the introduction of TH to post resuscitation care, a wide variety of cooling 
methods and devices have become available. ICNs play a central role in the 
implementation and clinical management of TH, the aim of the study was to compare 
different cooling devices with regard to key nursing aspects. 
Paper III. 
The implications of TH on accuracy of cerebral prognostication were largely 
unknown. Our aim was to study the clinical practice of cerebral prognostication after 
OHCA in Norway after nation-wide implementation of therapeutic hypothermia. 
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Paper IV. 
The HACA trial excluded OHCA patients older than 75 years, and there has been 
substantial debate about the application of TH in the oldest population. Our aim was 
to study outcome with TH in OHCA patients older than 75 years compared to younger 
patients. 
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3. Patients and methods 
3.1 Background data 
3.1.1 Setting and population 
Stavanger University Hospital serves as the primary medical centre for 300.000 
people and as a referral centre for approximately 400.000 people.46,114 Paramedic-
staffed ambulances cooperate with an emergency physician-staffed ambulance 
helicopter and rapid response car.115 Unconscious survivors of OHCA are assessed by 
an intensive care physician and a cardiologist in the emergency department (ED) for 
possible percutaneous coronary intervention (PCI) and intensive care therapy. 
Traditionally, unconscious OHCA survivors not acting in response to verbal 
command and devoid of terminal sickness have been admitted to a 12-bed general 
ICU for supportive care and two days of mechanical ventilation before weaning46. 
Cardiopulmonary resuscitation and post resuscitation care is performed according to 
current European and Norwegian Resuscitation guidelines.24,35,81,116 In 2002, we 
complemented our standard post resuscitation care with therapeutic hypothermia, 
using simple external cooling protocol of ice-water soaked towels over torso and 
limbs of the patient. During 2003, several commercial cooling devices were 
introduced in our ICU. In 2004, PCI availability was extended from daytime to 24-
hour service.114  
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3.2 Study design 
STUDY TOPIC DESIGN STUDY 
POPULATION 
STUDY 
PERIOD 
1 Implementation 
of TH 
Retrospective 
observational 
cohort study 
Comatose 
OHCA patients 
1/2001-
12/2003 
2 Nursing 
aspects of 
different 
cooling 
methods 
Survey ICU nurses May 2005 
3 Prognostication 
after OHCA 
Survey ICU Consultants  May 2005 
4 Use of TH in 
advanced age 
Retrospective 
observational 
cohort study 
Comatose 
OHCA patients 
fulfilling the 
HACA 
inclusion 
criteria 
6/2002-6/2008 
 TH-Therapeutic hypothermia, OHCA-Out-of-Hospital Cardiac Arrest, ICU-Intensive 
care unit, HACA-Hypothermia After Cardiac Arrest Study 
Table 2.  Study design 
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3.3 Data collection 
 
3.3.1 Local clinical information management systems 
The used prehospital cardiac arrest data was obtained from our local cardiac arrest 
registry based on the nationally approved Ustein template before they were 
anonymously transferred to the research study registry.3 The Utstein registry was 
established in 1996 and was approved for scientific use by the Regional Ethics 
Committee, the Central Office for National Registration and the Norwegian Social 
Science Data Service.46  
The hospital data variables were obtained from a national intensive care quality 
assurance database and local data related to the Northern Hypothermia Network. Most 
Norwegian ICUs gather data for quality assessment and resource management in a 
local database which exports data to the Norwegian Intensive Care Registry (NIR). 
The Norwegian Society of Anaesthesiology launched NIR in 1998 for mapping of 
Norwegian Intensive care activity and provision of quality assurance. NIR is one of 
the 36 national quality registries sanctioned by the National Data Security Council. 
Presently, 36 ICUs are reporting members of NIR.  
The Northern Hypothermia Network (NHN) was established in 2004, is supported by 
the Scandinavian Critical Care Trial Group (SCCTG) and represents a clinical and 
research network. In order to report follow-up data to the Northern Hypothermia 
Network (NHN), we established a local registry. The local data collection had been 
approved by the Norwegian Social Science Data Service. The Regional Ethics 
Committee of Western Norway had issued a statement in which the use of such data 
was considered as quality assurance and waived the need for individual informed 
consent. 
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Surveys 
The data for study II was collected during a 2-week period by means of an anonymous 
questionnaire filled out voluntarily by the ICNs employed in our ICU.  
The data for study III was collected by a voluntary, anonymous and semi-structured 
interview containing six structured questions. Interviewed were the ICU consultants 
in charge of the 25 Norwegian ICUs of the NIR admitting cardiac arrest patients. 
3.3.2 Ethics 
The data used in study I and IV were core routine data collected for the ICU and NIR 
database. The collected data was intended for on-going quality control.  The Regional 
Ethics Committee defined studies using such data as quality assurance research, and 
as no interventions were performed waived the need for informed consent. 
The data for studies II and III were collected by a voluntary, anonymous survey, and a 
semi-structured telephone interview which served as local and national quality 
assurance research. None of the surveys involved patient contact or collected patient 
related information. 
3.4 Data analysis and statistics 
Statistical computations were done by using a spreadsheet program (Excel, Microsoft 
Corp., Redmond, WA) and statistical software (SPSS, SPSS Inc., Chicago, IL). The 
Mann-Whitney test was used for continuous variables and the chi-square test for 
categorical variables. Demographic data is presented as medians with either 
maximum and minimum values or interquartile range. In study II the Kruskal-Wallis-
Test was used on ranked data. In study IV a multivariate logistic regression model and 
the Hosmer-and-Lemeshow-test for goodness of fit of the multivariate analysis were 
employed to analyse the data. A p-value of < 0, 05 was considered statistically 
significant. 
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3.5 Methods 
Paper I 
Twenty-seven OHCA patients were treated with our simple external cooling protocol 
within 18 months after implementation of TH and compared with a historical control 
of 34 OHCA patients, fulfilling TH-inclusion criteria and treated within 18 months 
before implementation in our ICU. Inclusion criteria were: (i) no response to verbal 
stimuli after ROSC independent of initial rhythm and cause of arrest, (ii) absence of 
cardiogenic shock - defined as systolic blood pressure < 90mmHg despite of 
vasopressor/inotrope use, and (iii) age 18-80 years. Cooling was initiated in the field 
by paramedics with sport ice packs and continued in the ICU with ice-water soaked 
towels (Picture 1.). All patients were mechanically ventilated, sedated with fentanyl 
and midazolam, as well as paralysed with cis-atracurium to avoid shivering. Target 
temperature (32°C-34°C) was attempted for 12-24 hours before passive rewarming 
was allowed.  
 
Picture 1.  Simple cooling method 
The temperature course of TH treated patients; Utstein template data, ICU-and 
hospital length of stay, adverse events during ICU stay, neurological outcome and 
survival to hospital discharge and 1-year survival were recorded. A Glasgow-
Pittsburgh Cerebral Performance Category (CPC) greater than two defined poor 
outcome. 
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Paper II 
Several cooling methods have been described for therapeutic hypothermia treatment 
(Table 2.) and numerous commercial devices are available for application.  
After implementation of a simple TH-protocol in our ICU in 2002 (Picture 1.), we 
introduced successively the CoolGard™3000 system (Alsius, Irvine, USA), the 
Thermowrap™ (MTRE, Yavne, Israel) and the ArticSun™ (Medivance, Louisville, 
USA) from 2003.   All new devices were introduced by a group of “super-users” 
including physician and nursing staff. The CoolGard™ system is an invasive cooling 
method, using a central venous catheter (Cool Line® or ICY® catheter) that works as 
a heat exchanger (Picture 2.).117 
 
Picture 2.  CoolGard™ and ICY® catheter (With permission of ZOLL) 
The Thermowrap™ (Picture 3.) and the ArticSun™ (Picture 4.) are non-invasive 
systems, which apply cold circulating water by means of a suit or adhesive pads. 
118,119 
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    Picture 3. Thermowrap™                                          Picture 4. ArticSun™    
   (With permission of MTRE)                                     (With permission of Medivance) 
All commercial devices use a close-loop temperature control system. The aim of our 
study was to evaluate awareness and features of implementation of TH among nursing 
staff, as well as compare the four cooling techniques, that were simultaneously 
available at that time in our ICU regarding key nursing aspects: hygiene, noise level, 
work load, ease of application, and visual patient monitoring. 
In May 2005, we delivered a structured anonymous survey (Box 2.) during a 2-week 
period in our 12-bed ICU, which we asked the nursing staff to complete.  
 
 
 
 
 
 
 
 
 41 
 
                                                        Questionnaire 
Number of years you have worked in the ICU…………….. 
Number of cooling patients since 2002   < 3 , 3-5, 5-10, > 10 
1. Did you understand the background for implementing therapeutic hypothermia (TH)?  Y / N / Partly 
2. Did you receive sufficient training in TH? Y / N  
3. Were you sufficiently prepared when TH was introduced? Y /N /Partly 
4. At the time of introduction, was there a written and sufficient cooling protocol in place? Y /N /Partly/Don t recall 
5. How do you consider the cooling protocol now? Comprehensive and complete-acceptable-incomplete 
6. Were you made aware of the potential complications? Y / N / Partly 
7. Has there been sufficient information about potential complications? Y / N / Partly 
8. Have you observed any problems related to TH yourself? No, if Y, what problems………………………….. 
9. Please list 3 potential complications with TH…………………………………………………………………. 
10. Is the collaboration between doctors and nurses good during treatment? Y/N/variable 
11. Is it difficult with many different cooling techniques in use at the same time? Y/N/Partly 
12. Please grade the 4 cooling techniques in use on a scale from 1-4 (1=worst and 4=best) 
 
Method Ease of 
application 
Visual pat. 
monitoring 
Work load Hygiene Noise level 
Wet towels      
CoolGard™      
Thermowrap™      
ArticSun™      
 
Box 2. Questionnaire 
 
Paper III 
In the spring of 2005, we conducted a semi-structured telephone interview with 
consultants of ICUs listed in the Norwegian Intensive Care Registry (NIR) admitting 
cardiac arrest patients. Six structured questions were asked, including involved 
medical specialities, time of prognostication, the tests used, use of TH, presence of a 
standardized protocol for prognostication, as well as personal evaluation of predictive 
value of different tests (Box 3.). 
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Cerebral prognostication after out-of-hospital cardiac arrest 
1. At what time after the return of spontaneous circulation (ROSC) is cerebral prognostication performed?            
                                         
         first 24 hours               24-48 hours            48-72 hours              after 3 days                        after 1 week 
2. Which medical specialties are involved in the prognostication of cardiac arrest survivors?                                           
             
        Anaesthesiologist⁯         Internal Med              Neurologist           Other _________         Multidisciplinary 
3. Which specific methods are applied for prognostication? 
              ⁯ Prehospital data (witnessed arrest, bystander CPR, initial ECG rhythm, no-flow time, CPR duration, prior 
health status)  
           ⁯ Neurological examination                   Somatic somatosensory evoked potentials (SSEP) 
           ⁯ Electroencephalogram (EEG)             Biochemical markers          Cranial computer tomography (CCT) 
           ⁯ Magnetic resonance imaging               Other____________________ 
4. According to you, which of the prognostic methods mentioned above has the greatest sensitivity/specificity? 
              ⁯ Prehospital data               Neurological examination              Somatic somatosensory evoked potentials (SSEP) 
           ⁯Electroencephalogram (EEG)                   Biochemical markers              Cranial computer tomography (CCT) 
              Magnetic resonance imaging (MRI)                                           Other____________________  
5. Do you use a standardised protocol for cerebral prognostication after OHCA? 
                                                              ⁯ Yes         ⁯ No 
6. Do you use therapeutic hypothermia after OHCA in your ICU?    
                                    ⁯ Yes         ⁯ No                                                            
Box 3. Cerebral prognostication survey 
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Paper IV 
We retrospectively studied all adult OHCA patients who were treated with TH in our 
ICU from 2002-2008. Inclusion criteria were the same as in the HACA study with 
exception of the upper age limit: bystander-witnessed cardiac arrest, presumed cardiac 
origin of arrest, VF or nonperfusing VT as initial ECG-rhythm, collapse-to-ROSC 
interval less than 60 minutes, absence of symptoms of cardiogenic shock at hospital 
admission, collapse to ambulance arrival and start of CPR 5 to 15 minutes. Study 
endpoint was outcome at hospital discharge. Poor outcome was defined by Glasgow-
Pittsburgh cerebral Performance category greater than two.  
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4. Results 
 
4.1 Paper I  
We identified 34 historic patients treated in our ICU within 18 months before the 
implementation of TH, who otherwise fulfilled the TH eligibility criteria. The 
implementation rate for TH was 100%, since all 27 patients eligible for the treatment 
received it. The simple cooling method required a median of 7, 5 hours to reach target 
temperature (TT) and was unable to obtain it in 11% of patients. TT was preserved for 
median 10 hours (6-19 hours) before passive rewarming, lasting median 10 hours (4-
17 hours), was initiated. Rebound hyperthermia developed in 89% of TH treated 
patients. There was no statistical significant difference between the two groups 
regarding the Utstein template data, length of ICU or hospital stay. Seizures were 
significantly less, hypokalaemia and insulin resistance significantly more common in 
the TH treated group. Survival rates to hospital discharge were significantly better in 
the group of patients that received therapeutic hypothermia (59% vs. 32%, p=0, 05).  
4.2 Paper II 
Fifty-nine nurses (98% response rate) participated in the survey. They had a median 
of 7 years of ICU work experience and had been involved in a median 5 hypothermia 
treatments. All of the 59 nurses had worked with the ice-water soaked towels, the 
CoolGard™ and the ArticSun™-system. Only 25 (42%) had used the Thermowrap™-
system in TH treatment. Ninety per cent of nurses felt they had good understanding of 
the background for TH, but merely 53% felt the initial training before was adequate 
and only 10% thought they were sufficiently prepared before the introduction of new 
methods. Seventy per cent felt partially prepared and 20% felt unprepared. With 
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regard to the existing cooling protocol only 20% answered that they thought it was 
comprehensive, whereas 70% of the nurses thought it was acceptable. 
Considering the key nursing elements, we found significant difference between the 
different devices. The ice-water soaked towels came in second to the ArticSun™-
system regarding ease of application, scored best in noise level and lowest in work 
load. The CoolGard™ and the ArticSun™-system achieved significantly better scores 
than the other methods.  For visual monitoring of the patient, the CoolGard™ scored 
highest. 
4.3 Paper III 
The twenty-five participating hospitals represented all geographic regions of Norway. 
Ninety-six per cent were anaesthesiologist-led, but a multidisciplinary approach to 
prognostication was followed in 76% of ICUs. The majority of hospitals (72%) 
conducted cerebral prognostication 24-48 hours after patient admission, the remaining 
after 48-72 hours. Prognostic parameters applied were: Somatosensory evoked 
potentials (SSEP) (8%), biochemical markers (8%), magnetic resonance imaging 
(MRI) (8%), electroencephalogram (EEG) (52%), cranial computer tomography 
(CCT) (58%), prehospital data (76%), and neurological examination (100%). TH was 
used routinely in 80% of ICUs, still only one ICU used a standardized protocol for 
cerebral prognostication. 
4.4 Paper IV 
We included 113 adult patients treated with TH after OHCA in our ICU from 2002-
2008 who fulfilled the HACA criteria with omission of the maximum upper age. 
Median age of the patients was 62 years (18-89 years), 77% were male, median time 
from collapse to ROSC was 15 minutes (3-50 minutes), bystander-CPR was 
performed in 76% and PCI in 63%. Overall good outcome was in achieved in 70% of 
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patients, and in 54% of patients older than 75 years. Collapse to ROSC time interval 
less than 15 minutes, age less than 62 years, applied bystander-CPR, and the time 
phase after implementation of the 2005 resuscitation guidelines were identified as 
independent predictors for good outcome in a multivariable analysis, whereas 
application of PCI and gender were not. Coronary angiography and PCI were 
performed significantly more frequent in patients under the age of 60 (74%, 35/47) 
than in patients aged older than 60 years (51% (34/66) (p=0, 02). 
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5. Discussion  
A decade ago two randomized controlled clinical trials showed that lowering the core 
body temperature to 32°-34°C for 12-24 hours in comatose survivors of out-of-
hospital cardiac arrest (OHCA) with ventricular fibrillation (VF) or non perfusing VT 
as initial ECG rhythm is associated with improved survival and neurological outcome. 
82,83 The use of TH was recommended for comatose survivors after OHCA by the 
International Liaison Committee on Resuscitation (ILCOR) in 2003.84 Many 
questions, however, regarding clinical management of TH after OHCA, risk of 
adverse events, timing, duration and method of cooling to be used, as well as the 
strength of presented evidence remained. 
In June 2002, one year before ILCOR published its TH recommendations, we added a 
simple external cooling protocol to the neurointensive care of OHCA patients in our 
institution. Due to the ease of application and the low costs of the method, as well as 
the presence of a clinical protocol and preparation of both nursing and physician staff, 
we were able to include all eligible OHCA patients from day one. In contrast to other 
studies, we found that rapid implementation of a simple cooling protocol to achieve 
TH is feasible (paper I). Implementation has been slow in countries like the UK, 
Germany, Czech Republic, and the USA.120-123 A recent American study reported 
utilization of TH in less than 1% of OHCA patients.124  Although our protocol was 
not successful to reach target temperature in 11% of patients and rebound 
hyperthermia was common, we found the method safe, inexpensive and associated 
with improved outcome. Problems with overcooling using ice packs and cooling 
blankets, as reported by Merchant et al., were not encountered in our study.125 The 
protocol used in our ICU did not burden the ICU or hospital budget since no 
additional purchase of medical equipment was necessary and the length of ICU and 
hospital stay was not prolonged. Storm and colleagues even proposed a significantly 
shortened time on mechanical ventilation and ICU stay for OHCA patients treated 
with TH.126 The overall cost effectiveness of TH in OHCA is comparable to other 
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health care interventions, e.g. public access defibrillation, as hypothermia treatment 
only accounts for approximately 1% of the total costs generated by cardiac arrest 
patients. The bulk of costs (99%) is created by post hypothermia in-hospital and post 
discharge care.127   
Despite compelling evidence on the outcome benefit of therapeutic hypothermia, 
implementation has been slow.128 Several barriers to implementation of TH into 
clinical practice have been described: insufficient evidence, technical challenges, 
concerns about adverse events, increased work load/lack of resources, adherence to 
local practice patterns, poor leadership, poor attitude, and high costs. 120,121,123,129-131 
After the two landmark studies showed reduced mortality and morbidity in VF-OHCA 
patients treated with TH, have numerous observational studies confirmed the 
beneficial results of TH.54,82,83,132,133 Paper I was among the first studies published in 
this context.24,54 Both, the 2005 and 2010 Resuscitation guidelines, a Cochrane report 
and a consensus report of five professional critical care societies have recommended 
TH in comatose OHCA survivors.14,35,134,135 Still, there is some controversy regarding 
further evaluation of TH. 136 Nielsen et al. included 478 TH-treated OHCA patients in 
a meta-analysis and a trial sequential analysis and conclude that the data provided is 
inconclusive, associated with risks of systematic and random errors, that quality of 
evidence is low and that a larger randomized trial is needed. The same investigator is 
currently recruiting patients for the international target temperature management after 
cardiac arrest trial (ClinicalTrials.gov number NCT01020916) and plans to evaluate 
the effect of different target temperatures (33°C vs. 36°C) in 850 OHCA survivors.  
Adverse events 
Arrhythmia, haemodynamic instability, bleeding, pneumonia, electrolyte disorders, 
sepsis, renal failure, seizures, pancreatitis and pulmonary oedema are potential 
adverse effects associated with TH in post resuscitation care.52 A recent review by 
Holzer reported a high rate of adverse effects in both the TH and the control group 
with 74% and 71% respectively. However, there was no statistical difference between 
the two groups.137 Our study showed that hypokalaemia and insulin resistance were 
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significantly more common in the TH-treated group, whereas seizures were 
significantly more common in the normothermic group. The low incidence of seizure 
reported in our TH-cohort is most likely due to continuous muscle relaxation during 
therapeutic hypothermia treatment which was abandoned during the revision of our 
post resuscitation protocol in 2005. Induction of electrolyte disorders is common and 
important problem of TH as low levels of magnesium, potassium, calcium and 
phosphate can cause cardiac arrhythmias and episodes of hypotension.104 
Hypokalaemia is associated with the development of polymorph ventricular 
tachycardia and cautious potassium supplementation is advocated to maintain serum 
levels at approximately 3 mmol/l.138 TH reduces insulin secretion and insulin 
sensitivity, frequently leading to hyperglycaemia.104 As hyperglycaemia is associated 
with worse neurological outcome after cardiac arrest as well as an increased incidence 
of infection, renal failure and critical care neuropathy, tight glucose control with 
insulin infusion is recommended.104,139 The registry-based study of 765 OHCA 
patients treated with TH by Nielsen et al. reported highest incidences of adverse 
events for pneumonia (48%), hyperglycaemia (37%), cardiac arrhythmia (tachycardia 
34%, bradycardia 14%), hypophosphatemia (19%), hypokalaemia (18%), 
hypomagnesaemia (17%), and seizures (24%). Bleeding requiring transfusion (6%) 
and sepsis (4%) were uncommon.140 The rates of adverse effects resemble those 
reported in our study results. A recent retrospective review by Mongardon and 
colleagues of 421 consecutive cardiac arrest patients, including 334 TH treated 
patients, confirmed a high incidence of infectious complications, especially 
pneumonia. Even though infections were more common in the TH group, they seem 
not to be associated with increased mortality.141 
Technical difficulties 
The time to achieve target temperature (TT) in our study was median 7,5 hours - 
approximately the same as in the HACA trial.83  The clinical benefit of reaching TT 
rapidly after or even before ROSC is still under debate. Even though prehospital 
cooling has been shown to be feasible in numerous studies, it was not associated with 
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improvement in outcome.142-144 Two registry-based studies of 986 and 452 TH treated 
OHCA survivors found no association of timing of TH and outcome.145,146 A recent 
review on intra-arrest cooling (IATH) concludes that it seems to be safe and feasible, 
improves neurological outcome in animal cardiac arrest models when compared to 
normothermia or post-ROSC hypothermia, and to have some positive effect on ROSC 
rates and the reduction of cardiac function after ROSC. Data on the outcome benefit 
in humans is still limited.147 Studies on the beneficial effects of TH on the 
myocardium propose increased myocardial salvage, reduced left-ventricular 
remodelling and decreased infarct seize, especially if TH is achieved before 
reperfusion.148,149 There exists general agreement to reach TT quickly and this can 
easily be accomplished by undressing the patient, applying ice-packs and infusing ice-
cold crystalloid.86  Cardiogenic shock was initially describes as a contraindication for 
TH in the landmark studies.82,83 We also applied this criterion as a contraindication 
for initiation of our TH protocol in our study (paper I). However, newer data suggests 
that TH might reduce mortality and provide circulatory support in acute cardiogenic 
shock.148,150  
In order to maintain TH, non-invasive and invasive techniques are available (Table 
2.). Our results of achieving stable maintenance TT with a simple cooling protocol 
concurs with other published data.151  Several commercial cooling devices exist, but a 
„low-tech - no cost” approach with cold crystalloid infusions and ice-packs/ice-water-
soaked towels is still feasible and might be especially appropriate for the community 
health setting with limited resources and a low OHCA-patient case load. In post 
resuscitation centres with higher case loads, however, the use of commercial devices 
has been widely accepted. The TH-cooling technique, as well as the commercial 
devices to be used, are commonly selected by doctors and then applied by ICU nurses. 
Toma et al. describes “interprofessional collaboration between nursing and physician 
staff” as a central element in the implementation process. Inconstant utilization of TH 
has been influenced by lacking awareness of the technique by the nursing staff and 
poor physician guidance.129 The acceptance of critical care methods among ICU 
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nurses is often associated with the contentment of key nursing aspects, like ease of 
application and patient monitoring, hygiene, noise level, and work load.  
In paper II we studied several available cooling appliances regarding core nursing 
elements. The conducted survey describes some interesting aspects of the different 
cooling methods and served as a quality assurance for our own implementation 
protocols. The ice-water soaked towels applied to torso and limbs were our original 
cooling method and scored high with regard to applicability and noise level. Even 
though hygiene and especially work load scored low, the simplicity and cost-
effectiveness of this method makes it especially appropriate for hospitals with low 
case loads of post resuscitation patients. Nevertheless, this has to be balanced against 
the increased work load and possible hygienic problems.  
All presented cooling methods are feasible for TH treatment after cardiac arrest.117-
119,151 Whether surface or core cooling is used, does not seem to influence outcome.152 
However, the target temperature of our TH treated patients could not be reached in 
11% and 89% of patients in the TH group experienced rebound hyperthermia (paper 
I).  Endovascular cooling appears to provide better control of temperature compared 
to surface cooling.153 Furthermore, the CoolGard™ offered better visual monitoring 
of the patient and scored high in hygiene. These advantages have to be weighed 
against the invasiveness and high costs of the method. With regard to implementation, 
it seems that our nurses had a good understanding of and high degree of concurrence 
with TH. However, the high percentage of nurses dissatisfied with the protocol and 
their preparation prior to implementation were concerning and stress the importance 
of on-going efforts to educate and reassess newly introduced protocols.  
The two landmark studies had numerous exclusion criteria (Table 1.), rejecting over 
90% of assessed OHCAs.82,83 The Hypothermia After Cardiac Arrest (HACA) study 
did not include patients older than 75 years and there is considerable debate whether 
the results can be extrapolated to this age group.24,83 As the incidence of OHCA 
increases with age and as octogenarians represent the fastest growing segment of the 
elderly population in the industrialized world, the outcome benefit of TH in elderly 
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OHCA patients is of great relevance (paper IV). 20,154 The impact of age in OHCA has 
been evaluated in several studies and there exists a general consensus that old age 
influences post resuscitation mortality, but is not associated with universal 
unfavourable neurological outcome. 16,155,156 These results are confirmed in paper IV, 
where, although poor outcome was independently associated with older age, 54% of 
OHCA survivors older than 75 years achieved good outcome. Even more surprising, 
more than half of the patients over 80 years recovered to a cerebral performance 
category (CPC) 1 or 2. The Norwegian post resuscitation consensus statement 
expressed as early as 2004 that age should not be a factor for withholding PCI or TH 
treatment.157 
Performance of bystander CPR and shorter time interval from collapse to ROSC are 
established predictors of good outcome.16,158 Both parameters were also independent 
variables for good outcome in paper IV. The reported range for prevalence of 
bystander CPR in industrialized countries ranges from 8-55%.159-161 The Stavanger 
region where we performed our retrospective cohort studies (paper I and IV) has rates 
of bystander CPR that are higher than reported.162  
The time phase after implementation of the 2005 resuscitation guidelines was also 
independently associated with improved outcome in paper IV. The 2005 CPR 
guidelines focused on uninterrupted and effective chest compressions, 
normoventilation, 1-shock defibrillation strategy immediately pursued by chest 
compressions and a simplified compression to ventilation ratio of 30:2. 35,131 The 
positive impact of the 2005 guideline changes on outcome in our study concurs with 
results reported by Aufderheide et al. and Hinchey and colleagues.163,164 The use of 
PCI did not reach statistical significance as an independent predictor of good outcome 
in paper IV, although several other studies have associated its use with improved 
outcome.165-167 Although acute PCI treatment was usually reserved for ST-elevation 
myocardial infarction (STEMI), it might also benefit cardiac arrest patients with other 
ECG rhythms, given that chest pain and ST-elevation represent poor markers of acute 
coronary obstruction in OHCA patients.24 Kern et al. suggest that ECG findings 
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should not be a decisive aspect whether or not to perform coronary angiography in the 
post ROSC period.168 However, both patient selection and the rather small sample 
seize may explain the failure to separate PCI as an independent prognostic factor in 
paper IV. OHCA patients younger than 60 years were significantly more likely to 
receive coronary angiography/PCI than older patients according to our study results 
(paper IV). Even though age is neither an exclusion criteria for TH in the national 
consensus statement or in our local protocol, physician discretion is permitted and 
might have been a source of selection bias. The association between older age and 
underutilization of evidence-based therapy, including early invasive management and 
revascularization, has been recognized in previous studies.169-171 
The combination of several therapies in post resuscitation care bundles, including 
early coronary angiography and PCI, TH, and hemodynamic support with inotropes 
and vasopressors was associated with improved outcome.75,172 Modern post 
resuscitation care implies highly specialized care from different medical specialties. 
In accordance with trauma and stroke centers, the regionalization of post cardiac 
arrest patients seems to be related to improve outcome.44,173 Longer prehospital 
transport intervals from triaging OHCA patients after ROSC directly to post 
resuscitation centers does not affect survival.174 
Prognostication after cardiac arrest 
In spite of advances in prehospital and hospital care, survival to discharge after 
OHCA has remained low in most areas with many survivors suffering from 
neurological sequelae.160,175 Death, persistent coma, vegetative state or severe 
neurological disability rendering the patient reliant on daily support defines poor 
outcome after cardiac arrest.23 Dependable prognostication of poor outcome is 
essential in order to avoid futile treatment and to reduce the emotional, as well as the 
financial burden on families and health care systems.126,176 One could speculate that 
the changes in post resuscitation care with the introduction of TH and the transformed 
clinical course of OHCA survivors should mandate an increased vigilance in the 
prognostication approach. In early 2005, after nation-wide implementation of TH, we 
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conducted a survey to investigate if clinical prognostication patterns had changed 
along with altered post resuscitation therapy (paper III). In 2010, resuscitation 
guidelines acknowledged that among the most important developments since the 2005 
ILCOR recommendations was the realization that the use of TH in post resuscitation 
management challenges many traditionally established prognostic parameters.47 
Numerous parameters have been described in cerebral prognostication after cardiac 
arrest. However, few offer false predictive rates that approach zero and there exists 
only sparse data on the impact of TH on their accuracy. Cerebral prognostication had 
long been based on the work of Levy et al. from 1985, using an algorithm of brain 
stem reflexes, motor, verbal response and eye opening, as well as the duration of 
coma. 177 The 2000 resuscitation guidelines had not been updated at the time the 
survey was conducted and did not contain any specific information for the approach 
to prognostication after cardiac arrest.178 In 2002, the Austrian Interdisciplinary 
Consensus Conference described 26 parameters that enable the clinician to make a 
prognostic assessment. However, only a GCS < 5 or absent pupillary reflex at day 3, 
seizures at day 3-7 post ROSC, absent N20 somatosensory evoked potential (SSEP) 
response within 7 days post ROSC and a neuron-specific enolase (NSE) level > 
33μg/ml were described to have a positive predictive value of 100% for poor 
outcome. 179 Predictive parameters with proven insufficient predictive value are: sex, 
age, cause of arrest, type of initial ECG-rhythm, initial Glasgow-Coma-Score, 
elevated body temperature, time interval of total arrest time, and the duration of 
CPR.112,180 
 The 2005 ERC guidelines state that laboratory analyses like NSE, S-100β, base 
deficit, glucose level or soluble P-selectin do not represent reliable prognostic 
parameters. Somatosensory evoked potentials (SSEP) measured at 72 hours after 
ROSC have 100% specificity for poor outcome and that the use of 
electroencephalography (EEG) performed 24-48 hours after arrest can be helpful in 
prognosis assessment.35 The 2005 American Heart Association (AHA) guidelines for 
post resuscitation care state that no single predictor can reliable prognosticate poor 
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outcome. Further, an EEG performed 24-48 hours after ROSC is described as “useful 
predictive information”. As reliable predictors for poor outcome, somatosensory 
evoked potentials (SSEP) measured 72 hours after ROSC and 5 clinical signs are 
given.181 
The clinical signs to predict unfavorable outcome or death are:  
x  At 24 hours after ROSC: absent corneal reflex, absent pupillary reflex, absent 
withdrawal to pain, no motor response 
x At 72 hours after ROSC: no motor response 
In lack of a clinical applicable prognostic post resuscitation algorithm issued by the 
major resuscitation organizations, the American Academy of Neurology issued a 
decision algorithm in 2006 based on parameters (brain stem reflexes, early myoclonic 
status epilepticus, SSEP, NSE, motor response) with FPR of zero with narrow 
confidence intervals (CI) tested on day 1-3 after cardiac arrest. Major confounding 
factors for the application of this algorithm contain shock, residual sedation, residual 
muscle relaxation, renal or hepatic failure and use of therapeutic hypothermia.180 
Timing of prognostication 
There exists a general consensus that prognostic accuracy improves with time after 
the onset of coma.110 Traditionally, the majority of comatose OHCA survivors usually 
emerged within 3 days, and all with good neurological outcome did so within 2 
weeks.182 Moreover, delay to day three accounts for the unreliability of brain stem 
reflexes and the GCS – the mainstay of neurological examination-within the first 48 
hours. 183,184 All of the ICUs in our survey conducted prognostication within 72 hours, 
the majority even within 24-48 hours. This practice yields the potential danger of rash 
limitation or withdrawal of care and the inclination of self-fulfilling prophecies. 
Furthermore, 80% of surveyed ICUs used TH routinely. The effect of therapeutic 
hypothermia on traditional predictive parameters has not been amply evaluated and 
therefore caution is warranted when these are used to found a limit-or-withdraw –care 
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decision in TH treated patients. Surprisingly, an American study from 2012, found a 
similar pattern of early assignment of poor prognosis and possibly premature 
withdrawal of care within 72 hours post cardiac arrest in their TH treated OHCA 
cohort. 185  
Prognostic parameters 
A multimodal approach increases the prognostic accuracy and all of the surveyed 
ICUs (paper III) relied on more than one prognostic parameter for their decision to 
limit or withdraw care.180 The most frequently applied parameter was clinical 
neurologic examination. This predictive variable has been extensively studied and 
validated as a parameter for comatose OHCA survivors. In lack of confounding 
factors, like use of hypothermia, muscle relaxants, large doses of sedatives, as well as 
the presence of organ dysfunction and shock, neurological evaluation represents a 
reliable factor of prognostication.180 A recent study by Rossetti et al. validated the 
2006 American Academy of Neurology prognostication algorithm and found that 
clinical neurological examination 36- 72 hours post ROSC was unreliable. The 
documented false predicted rates (FPR) for unfavourable outcome were significantly 
higher than reported in the algorithm: > 1 absent brain stem reflexes (4% vs. 0%), 
early myoclonus status epilepticus (3% vs. 0%), and motor response less than flexion 
(24% vs. 0%).186 Status epilepticus in post resuscitation patients who received TH 
treatment is associated with a FPR of 7-11, 5 % for poor outcome. 187,188 
Unexpectedly, the second most frequent parameter used in our study was prehospital 
data. Even though several of these parameters are associated with unfavourable 
functional outcome, their high FPR prohibit accurate dichotomization between good 
and poor outcome. 180 The international resuscitation guidelines describe prehospital 
data as unreliable predictors for prognostication. 24,47,131 
Studies on the predictive value of cranial computer tomography (CCT) and magnetic 
resonance imaging (MRI) in anoxic-ischemic coma have associated several findings 
with poor outcome. Their role in prognostication, however, remains undetermined due 
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to the small number of studied patients, wide variety of tested parameters and timing 
of examinations. 24,47 CCT was used in over half of surveyed ICUs, whereas MRI 
only played a minor role. CCT was rated as having minor importance in 
prognostication according to the interviewed consultants, but its use is suggested in 
exclusion of structural causes of coma.24 Even though MRI is superior to CCT in 
demonstrating cerebral lesions after global hypoxic-ischemic events, the lack of 
evidence and the potentials hazards of transporting a critical ill patient to the MRI lab 
challenge its use in prognostication after cardiac arrest. 24 
Electroencephalography (EEG) has been comprehensively evaluated as a prognostic 
predictor after cardiac arrest and a meta-analysis showed a FPR of 3% (95%CI 0, 9-
11%) for malignant pattern within 72 hours post ROSC in patients not treated with 
TH.180 It was used in over half of all surveyed ICUs (paper III). According to current 
guidelines are EEG results alone not suited to predict futility.24,47 However, in 
absence of confounding factors, Rosetti et al. presented FPRs of zero for unreactive 
EEG background activity in TH treated OHCA patients.186  
Somatosensory evoked potentials (SSEP) are less susceptible to metabolic disorders 
or drugs than EEG.189 The absence of the bilateral N20 response in comatose 
survivors not treated with TH 24 hours after ROSC predicted poor outcome with FPR 
0, 7 (95%CI 0, 1-3, 7%) and their use is encouraged by international resuscitation 
guidelines.24,47,180 Our study, however, showed that SSEP was applied in only two 
surveyed ICUs and was not regarded as an important technique in cerebral 
prognostication. Lack of awareness, limited accessibility, as well as lack of 
experience with this test might be possible explanations. SSEP seem to be a reliable 
predictor also in TH treated patients with FPR of 0%.186,190 However, Leithner et al. 
reported a FPR of 3% for SSEP recorded later than 24 hours post ROSC. Two TH 
treated OHCA patients of this study, presented absent SSEP 72 hours after ROSC and 
still made a good recovery. 191  
Several biochemicals such as neuron-specific enolase (NSE), S100β, neurofilament 
protein and creatine kinase brain isoenzyme (CK-BB) have been investigated for 
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outcome prediction after cardiac arrest but played only a minor role in our study 
(paper III). A systemic review associated NSE levels > 33ug/L within 24 hours after 
ROSC to invariably poor outcome, whereas studies on S100β, CK-BB and 
neurofilament protein showed poor prognostic ability.180 Data on the predictive 
accuracy of NSE in patients treated with TH has shown conflicting results. 192-195   
Additionally, assays for these markers are not commonly available in many countries, 
including Norway. Current resuscitation guidelines do not support the sole use of 
biomarkers to evaluate outcome in post cardiac survivors and several studies have 
reported. 24,47  
The current resuscitation guidelines suggest a combination of predictive modalities 
should be used in TH treated OHCA patients since every single prognostic test had 
FPRs greater than zero reported. Absent N20 SSEP response or unreactive 
background on EEG at 36-72 hours after admission, as well as lack of pupillary and 
corneal reflex > 72 hours post ROSC are regarded as accurate parameters, whereas 
biomarkers were marked as adjunctive. Status epilepticus and motor response less 
than flexion are considered unreliable signs for prognostication.47 
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6. Main findings 
Paper I 
Rapid implementation of therapeutic hypothermia with a simple external cooling 
protocol was feasible in 100% of eligible patients. It was safe, added no extra costs 
and almost doubled survival to hospital discharge compared to a historic control 
group. Safety or cost concerns need not be a barrier for implementation of TH. 
Paper II 
The evaluated cooling methods differed significantly with regard to key nursing 
aspects. Simple external cooling methods are still feasible and might be especially 
appropriate for smaller hospitals with low OHCA case loads. 
Paper III 
Despite the high (80%) use of therapeutic hypothermia, most Norwegian ICUs 
performed prognostication early in the post resuscitation phase and founded decisions 
on mainly neurological examination, prehospital data, CCT and EEG findings. 
Somatosensory evoked potentials were underused, whereas predictive accuracy of 
prehospital data, CCT and EEG appears overrated. 
Paper IV 
Although age affects outcome in cardiac arrest, comatose survivors older than 75 
years had good outcome in more than 50% of cases. Limitation of post cardiac arrest 
care should not be based on age alone. 
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7. Limitations of the studies 
Paper I: The retrospective, single centre study design and small patient population 
limit the extent of conclusion that can be drawn from this study. Physician bias for 
exclusion of OHCA patients for TH treatment was possible. The temperature course 
of the normothermic patient group was not available. 
Paper II: Single centre study with a small number of participants with limited 
numbers of cooling procedures. Not all nurses had worked with all cooling devices.  
Paper III: Only one physician per hospital was interviewed during the survey and thus 
the collected data might not represent the general practice at the institution. The study 
has limited international validity as only Norwegian ICUs were included. No 
information was made available whether the timing of prognostication impacted 
decisions to limit active treatment. 
Paper IV: Non-randomized cohort design in a single centre with a short follow-up 
interval. Patient selection bias for both PCI and/or TH treatment was possible. Data 
on co-morbidities and baseline health status were not available for the multivariate 
analysis. The group of patients studied only constitutes a small portion of all assessed 
OHCA and thus extrapolation of our results to other subgroups of elderly OHCA 
patients, like non-witnessed or non-shockable arrests might not be appropriate. 
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8. Future aspects 
In order to transform new evidence into daily clinical practice and support rapid, 
wide-spread implementation, the academic bodies of resuscitation could consider to 
incorporate more detailed, but user-friendly protocols in the resuscitation updates, 
combined with a time schedule in which implementation of the evidence should be 
completed.  
The optimal cooling method, benefit of intra-arrest cooling, velocity of induction, 
duration and rewarming rate are still undetermined. Data on the role of ICNs as key 
players in the implementation process and in the practical application of TH is still 
rare. Many questions remain about the optimal temperature management of cardiac 
arrest patients. The published data support a target temperature of 32°-34°C for 12-24 
hours, however, the optimal temperature range, possibly individualized for every 
patient, has not been determined.  
The 2 landmark studies evaluated only a small portion of OHCAs and in order to 
establish the benefit of TH in other subgroups of cardiac arrest further studies are 
warranted.  
More data are required about timing and accuracy of established prognostic 
parameters in comatose OHCA patients treated with TH. 
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9. Erratum 
 
Paper IV 
The abstract of paper 4 states incorrectly bystander CPR as an inclusion criteria for 
the HACA study. 
 The Wilcoxon`s rank test was not applied in the data analysis of this paper.  
Merely the p-value for the difference of the use of PCI for patients older and younger 
than 60 years was given. Patients younger than 60 years (35/47) received PCI 
significantly more frequent than patients older than 60 years (34/66). The figures 
given, depict the numbers of patients younger (47/113) and older than 60 years 
(66/113). 
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